The Run Bai Yan Bo Uric Acid of Huaxi Bio is true. Runbaiyan produced by Huaxi Biotech was approved by CFDA on 20 12, and it is the first cross-linked hyaluronic acid soft tissue filler with approval number in China. After Huaxi Bio's Runbaiyan became the first hyaluronic acid brand certified by CFDA on 20 12, it increased to 13 on 20 16.

Runbaiyan of Huaxi Bio occupies about 15% market share. Huaxi Bio is the world's largest producer and seller of hyaluronic acid, accounting for 36% of the global market share of hyaluronic acid raw materials in 20 18, and significantly leading the second place in the global market share 12%.

Extended data

Huaxi Bio also participated in drafting four national industry standards for hyaluronic acid in the fields of cosmetics, plastic surgery and tissue engineering, participated in revising the standards for hyaluronic acid in the European Pharmacopoeia and the China Pharmacopoeia, and submitted a monograph on hyaluronic acid in the United States Pharmacopoeia.

The development and growth of Huaxi Bio-industry for more than 20 years just alludes to the development of hyaluronic acid industry in China. In order to better cope with the opportunities and challenges brought by the vast market, Huaxi Bio has carried out application innovation in recent years and gradually opened up the C-end market. The popularity and sales of functional skin care products such as Runbaiyan are increasing day by day, which are favored by consumers.

References:

China Economic Net-Huaxi Biological Breakthrough Science and Technology Innovation Board: The quality of hyaluronic acid leading scientific research is "insufficient"

References:

China Economic Net-Huaxi Bio: From breakthrough to transcendence, the 20-year change of hyaluronic acid technology in China